Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors
- PMID: 20358273
- PMCID: PMC2909482
- DOI: 10.1007/s10508-010-9619-y
Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors
Abstract
Mounting evidence indicates that erectile dysfunction medications (EDMs) have become increasingly used as a sexual enhancement aid among men without a medical indication. Recreational EDM use has been associated with increased sexual risk behaviors, an increased risk for STIs, including incident HIV infection, and high rates of concomitant illicit drug use. The aim of the present study was to investigate the characteristics and associated risk factors for recreational EDM use among young, healthy, undergraduate men. A cross-sectional sample of 1,944 men were recruited from 497 undergraduate institutions within the Unites States between January 2006 and May 2007. The survey assessed patterns of EDM use, as well as demographic, substance use, and sexual behavior characteristics. Four percent of participants had recreationally used an EDM at some point in their lives, with 1.4% reporting current use. The majority of recreational EDM users reported mixing EDMs with illicit drugs and particularly during risky sexual behaviors. Recreational EDM use was independently associated with increased age, gay, or bisexual sexual orientation, drug abuse, lifetime number of sex partners, and lifetime number of "one-night stands." Recreational EDM users also reported a 2.5-fold rate of erectile difficulties compared to nonusers. Overall, recreational use of EDMs was associated with sexual risk behaviors and substance abuse; however, a relatively small proportion of undergraduates reported using EDMs. Results also suggest that a sizable portion of recreational EDM users are heterosexual men, and that use does not solely occur within the environments of venues that cater to men having sex with men.
Similar articles
-
Off-Label Use of Phosphodiesterase Type 5 Inhibitor Erectile Dysfunction Medication to Enhance Sex Among Gay and Bisexual Men in Australia: Results From the FLUX Study.J Sex Med. 2017 Jun;14(6):774-784. doi: 10.1016/j.jsxm.2017.04.670. J Sex Med. 2017. PMID: 28583339
-
Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men: the mediating role of confidence in erectile ability.J Sex Med. 2012 Jul;9(7):1852-9. doi: 10.1111/j.1743-6109.2012.02755.x. Epub 2012 May 8. J Sex Med. 2012. PMID: 22568639
-
Phosphodiesterase Type-5 Inhibitor Prescription Patterns in the United States Among Men With Erectile Dysfunction: An Update.J Sex Med. 2020 May;17(5):941-948. doi: 10.1016/j.jsxm.2020.01.027. Epub 2020 Mar 3. J Sex Med. 2020. PMID: 32144034 Free PMC article.
-
Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.Expert Opin Pharmacother. 2005 Jan;6(1):75-84. doi: 10.1517/14656566.6.1.75. Expert Opin Pharmacother. 2005. PMID: 15709885 Review.
-
Phosphodiesterase 5 inhibitors in male sexual dysfunction.Curr Opin Urol. 2003 Sep;13(5):405-10. doi: 10.1097/00042307-200309000-00008. Curr Opin Urol. 2003. PMID: 12917517 Review.
Cited by
-
Evidence for benefits and risks of tadalafil as a non-prescription medicine: review and evaluation using the Group Delphi technique to achieve consensus amongst clinical experts.Front Pharmacol. 2023 Oct 9;14:1254706. doi: 10.3389/fphar.2023.1254706. eCollection 2023. Front Pharmacol. 2023. PMID: 37876727 Free PMC article.
-
Sildenafil citrate use in Addis Ababa: characteristics of users and pharmacists' dispensing practices.Int J Clin Pharm. 2018 Feb;40(1):67-73. doi: 10.1007/s11096-017-0558-8. Epub 2017 Nov 14. Int J Clin Pharm. 2018. PMID: 29134487
-
Quality of online pharmacies and websites selling prescription drugs: a systematic review.J Med Internet Res. 2011 Sep 30;13(3):e74. doi: 10.2196/jmir.1795. J Med Internet Res. 2011. PMID: 21965220 Free PMC article.
-
Sexual medicine: the psychological effects of recreational PDE5 inhibitor use.Nat Rev Urol. 2012 Sep;9(9):479-80. doi: 10.1038/nrurol.2012.149. Epub 2012 Jul 31. Nat Rev Urol. 2012. PMID: 22847548 No abstract available.
-
Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors among Undergraduate Male Students in an Ethiopian University: A Cross-Sectional Study.World J Mens Health. 2016 Dec;34(3):186-193. doi: 10.5534/wjmh.2016.34.3.186. Epub 2016 Dec 22. World J Mens Health. 2016. PMID: 28053948 Free PMC article.
References
-
- Benotsch EG, Seeley S, Mikytuck JJ, Pinkerton SD, Nettles CD, Ragsdale K. Substance use, medications for sexual facilitation, and sexual risk behavior among traveling men who have sex with men. Sexually Transmitted Diseases. 2006;33:706–711. - PubMed
-
- Cachey E, Mar-Tang M, Mathews W. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care and STDs. 2004;18:349–354. - PubMed
-
- Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346–351. - PubMed
-
- Chu PL, McFarland W, Gibson S, Weide D, Henne J, Miller P, et al. Viagra use in a community-recruited sample of men who have sex with men, San Francisco. Journal of Acquired Immune Deficiency Syndromes. 2003;33:191–193. - PubMed
-
- Colfax G, Mansergh G, Guzman R, Vittinghoff E, Marks G, Rader M, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison. Journal of Acquired Immune Deficiency Syndromes. 2001;28:373–379. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources